- Home
- Our Vision
- UGI Newsletter
- Research
- MSc Courses
- MSc Genetics of Human Disease
- MSc Pharmacogenetics and stratified Medicine
- MSc News
- What is Pharmacogenetics and Stratified Medicine?
- UGI Core Services
- Staff
- Gene Ontology
- FH Variant Databases
- Vacancies
- Resources
- UGI Calendar
- Contact Us
MSc in Pharmacogenetics and Stratified Medicine
The MSc in Pharmacogenetics and Stratified Medicine will provide scientists
and clinicians with an in-depth knowledge of: the pharmacology of drugs; the
consequences of drug treatment for individuals with respect to their genotype;
the analysis and statistical methods used to study population groups and how
this knowledge can be applied to improve human health, drug efficacy and
alleviate human disease through the development and application of diagnostic
tests or therapeutic agents.
Who is the programme for?
The programme is designed for those with undergraduate qualifications in the life sciences, individuals from the pharmaceutical and biotechnology industries, scientists and clinicians. The knowledge and transferable skills developed in the course will be suitable for those in an industrial or healthcare setting, as well as those individuals contemplating further PhD studies.
UCL - London's Global University
UCL is a leading centre of internationally recognised research in the field of pharmacology, biochemistry and human genetics and these strengths, both academic and clinical, are being harnessed to bring together this cross-faculty initiative in a rapidly growing area of science. UCL is in a unique position to offer students both the basic science and application of pharmaco-genetics to improve human health, including multi-disciplinary outreach across the college.
Career Prospects
Students emerge well-versed in the different tools and scientific disciplines which will allow them to make full use of the wide ranging genetic discoveries that have happened over the past decade and will increasingly inform our understanding of human biology and disease. This positions them well for studentships in laboratories using genetic techniques to examine diseases such as heart disease, cancer and neurological disorders. Another large group will seek research jobs in the pharmaceutical industry, where an advanced training in laboratory genetic techniques as well as bioinformatic and statistical experience will be of value.
CLOSING DATE 30 June 2013 - NON-EU APPLICANTS.
CLOSING DATE 3 August 2013 - UK and EU applicants
UK and EU applications, after the closing date, will be considered but are highly likely to be put on a waiting list as the number of students will be limited to 20.
|
For Academic queries, please contact: |
For Administrative queries, please contact: |
|
Dr Elvira Mambetisaeva e.mambetisaeva@ucl.ac.uk + (44) 020 3108 4006 |
Mrs Sue Walsh susan.walsh@ucl.ac.uk + (44) 020 7679 4168 |
Page last modified on 03 dec 12 11:40


